Total Pageviews

5/02/2013

Culture War taking toll on Jon Stewart


Good to see the bitterness of the culture war is taking it's toll on a decadent like Jon Stewart. He looks haggard, and his voice is increasingly shrill. He is losing his edge.

It's easy to point out the litany of contradictions and absurd arm chair political claims of Fox News pundits. But if this is true then it is even more so for the absurd and vile nonsense spewed by MSNBC, CNN, and others. Not to mention the dirty secret that the tiger-lily socialists and hipster college crowd liberals are just as much in favor of a police state as the corrupt conservative quarters in this country.

The fact of the matter is both sides have effectively done away with much of the protections and rights afforded in the US constitution. Through some strange twist of fate, the 2A is one of the few or even only remaining amendments that actually means anything by this date, but as we know too well they are working furiously to change that. I myself am not a strict constitutionalist having been turned by the likes of Lysander Spooner, and much to the chagrin of the gun-grabbing pundits.

Jon Stewart cherry picks his own amendments for that matter. In his heart of hearts he hates the idea that "little people" can defend themselves with firearms while rich Hollywood liberal elites like him have to pay for armed security (no fair!). Jon Stewart is a hypocrite in every regard when and where he has spoken about firearms and firearm access in American society.
April 27 at 3:31pm · Like

1 comment:

  1. FDA approved the first treatment of medullary thyroid cancer drug vandetanib

    April 6, 2011, according to the U.S. FDA website reports, the approval of vandetanib for the treatment of adult advanced medullary thyroid cancer, these patients not suitable for surgery, the tumor continued to increase or cause symptoms.

    Thyroid cancer is a tumor of the neck thyroid. Medullary thyroid carcinoma is a particular type of cell in the thyroid gland, can be spontaneous or part of a genetic syndrome.

    According to the U.S. National Cancer Institute, the United States during 2010 newly diagnosed about 44,600 cases of thyroid cancer cases, about 1,690 people die from the disease. Medullary thyroid cancer is estimated to account for 3% -5% of all thyroid cancer; It is estimated that the United States in 2010 medullary thyroid cancer incidence is about 1300-2200, is one of the rare type of thyroid cancer. Further reading: U.S. FDA approved the first treatment of medullary thyroid cancer drug vandetanib

    Medchemexpress Can provide the above product,its website:www.medchemexpress.com



    TG 100572
    Bosutinib
    Nilotinib
    Dasatinib
    Saracatinib
    Fingolimod
    Bafetinib
    R406 free base
    R406
    R788(prodrug of R406)

    ReplyDelete